As of 2024-07-27, the Fair Value of Supernus Pharmaceuticals Inc (SUPN) is -1.41 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 30.75 USD, the upside of Supernus Pharmaceuticals Inc is -104.59%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | 113.10 | 127.00 | 53.40 | 60.70 | 1.32 | 71.10 |
| YoY growth | 1.89% | 12.29% | -57.95% | 13.67% | -97.83% | -25.59% |
| Market Cap (mil) | 1,690.33 |
| P/E | |
| Forward P/E | 345.53x |
| EPS | -0.28 |
| Avg earnings growth rate | -25.59% |
| TTM earnings | -15.50 |